Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Founded in 2021, Isomorphic Labs is a subsidiary of Google parent Alphabet. It is currently preparing to dose the first patients with the AI-engineered drug in clinical trials and is “staffing up” ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

China has launched a controversial new civilian flight path near Taiwan, saying the route will reduce air traffic congestion.

Isomorphic Labs, an AI-first drug discovery company, has announced the appointment of Ben B. Wolf as chief medical officer. Dr. Wolf will be based in the company's newly established Cambridge location ...

(The Center Square) – The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ genetic data to international labs. Based on “mounting ...

Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. LONDON and BOSTON, June 17, 2025 /PRNewswire/ -- ...

Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...

In clinical practice, injectable glucagon-like peptide-1 (GLP-1) receptor agonists for obesity treatment appear less effective than in clinical trials, largely due to early discontinuation and low ...